JPH11193282A5 - - Google Patents

Info

Publication number
JPH11193282A5
JPH11193282A5 JP1997367887A JP36788797A JPH11193282A5 JP H11193282 A5 JPH11193282 A5 JP H11193282A5 JP 1997367887 A JP1997367887 A JP 1997367887A JP 36788797 A JP36788797 A JP 36788797A JP H11193282 A5 JPH11193282 A5 JP H11193282A5
Authority
JP
Japan
Prior art keywords
group
substituted
aroyl
alkyl
alkanoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997367887A
Other languages
English (en)
Japanese (ja)
Other versions
JP4189048B2 (ja
JPH11193282A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP36788797A priority Critical patent/JP4189048B2/ja
Priority claimed from JP36788797A external-priority patent/JP4189048B2/ja
Publication of JPH11193282A publication Critical patent/JPH11193282A/ja
Publication of JPH11193282A5 publication Critical patent/JPH11193282A5/ja
Application granted granted Critical
Publication of JP4189048B2 publication Critical patent/JP4189048B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP36788797A 1997-12-26 1997-12-26 複素環化合物 Expired - Fee Related JP4189048B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP36788797A JP4189048B2 (ja) 1997-12-26 1997-12-26 複素環化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP36788797A JP4189048B2 (ja) 1997-12-26 1997-12-26 複素環化合物

Publications (3)

Publication Number Publication Date
JPH11193282A JPH11193282A (ja) 1999-07-21
JPH11193282A5 true JPH11193282A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2005-09-02
JP4189048B2 JP4189048B2 (ja) 2008-12-03

Family

ID=18490454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP36788797A Expired - Fee Related JP4189048B2 (ja) 1997-12-26 1997-12-26 複素環化合物

Country Status (1)

Country Link
JP (1) JP4189048B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1250548C (zh) 2001-04-17 2006-04-12 大日本住友制药株式会社 新的腺嘌呤衍生物
BR0314761A (pt) 2002-09-27 2005-07-26 Sumitomo Pharma Composto de adenina e seu uso
CA2537450C (en) * 2003-09-05 2012-04-17 Anadys Pharmaceuticals, Inc. Administration of tlr7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus
NZ549903A (en) 2004-03-26 2010-04-30 Astrazeneca Ab 9-substituted 8-oxoadenine compound
US20090324551A1 (en) 2005-08-22 2009-12-31 The Regents Of The University Of California Office Of Technology Transfer Tlr agonists
KR20080085232A (ko) 2006-02-17 2008-09-23 화이자 리미티드 Tlr7 조절제로서 3-데아자퓨린 유도체
WO2008004948A1 (en) 2006-07-05 2008-01-10 Astrazeneca Ab 8-oxoadenine derivatives acting as modulators of tlr7
TW200831105A (en) 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
PL2510946T3 (pl) 2007-02-07 2015-12-31 Univ California Koniugaty syntetycznych agonistów tlr i ich zastosowania
ES2373616T3 (es) 2007-03-19 2012-02-07 Astrazeneca Ab Compuestos de 8-oxo-adenina 9 sustituidos como moduladores del receptor de tipo toll (tlr7).
ES2457316T3 (es) 2007-03-19 2014-04-25 Astrazeneca Ab Compuestos 8-oxo-adenina 9 sustituidos como moduladores del receptor similares a toll (TLR7)
PE20081887A1 (es) * 2007-03-20 2009-01-16 Dainippon Sumitomo Pharma Co Nuevo compuesto de adenina
US8044056B2 (en) 2007-03-20 2011-10-25 Dainippon Sumitomo Pharma Co., Ltd. Adenine compound
US8436178B2 (en) 2007-05-08 2013-05-07 Astrazeneca Ab Imidazoquinolines with immuno-modulating properties
PE20091236A1 (es) 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
PE20091156A1 (es) 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
WO2009091032A1 (ja) 2008-01-17 2009-07-23 Dainippon Sumitomo Pharma Co., Ltd. アデニン化合物の製造方法
WO2010088924A1 (en) 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
GB0908772D0 (en) 2009-05-21 2009-07-01 Astrazeneca Ab New salts 756
US20120122867A1 (en) 2009-05-21 2012-05-17 Nicholas James Bennet Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
CA2777824C (en) 2009-10-22 2016-11-29 Gilead Sciences, Inc. Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
US9050319B2 (en) 2010-04-30 2015-06-09 Telormedix, Sa Phospholipid drug analogs
CN103221067B (zh) 2010-04-30 2016-01-06 泰勒麦迪克斯公司 磷脂药物类似物
EP2651937B8 (en) 2010-12-16 2016-07-13 Sumitomo Dainippon Pharma Co., Ltd. Imidazo[4,5-c]quinolin-1-yl derivative useful in therapy
ES2627433T3 (es) 2010-12-17 2017-07-28 Sumitomo Dainippon Pharma Co., Ltd. Derivados de purina
MY178053A (en) 2012-05-18 2020-09-30 Sumitomo Dainippon Pharma Co Ltd Carboxylic acid compounds
NZ735648A (en) * 2015-05-08 2023-06-30 Hoffmann La Roche Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms
TWI671300B (zh) 2016-08-29 2019-09-11 瑞士商赫孚孟拉羅股份公司 用於治療及預防病毒感染之新穎7–經取代磺醯亞胺醯基嘌呤酮化合物及衍生物
EP3970750A1 (en) 2016-09-13 2022-03-23 F. Hoffmann-La Roche AG Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor
JP7328977B2 (ja) * 2018-02-12 2023-08-17 エフ. ホフマン-ラ ロシュ アーゲー ウイルス感染の処置および予防のための新規のスルホン化合物および誘導体
EP3758707A1 (en) 2018-02-28 2021-01-06 F. Hoffmann-La Roche AG 7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of liver cancer

Similar Documents

Publication Publication Date Title
JPH11193282A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2004518723A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK1487829T3 (da) Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte
JP2005515255A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GEP20074099B (en) 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
CA2436846A1 (en) Thioether substituted imidazoquinolines
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
LU90956I2 (fr) Metvix principe actif méthylaminolevulinique sous forme d'un selde préférence l'hyhrochlorure méthylaminolevulinique
CA2107014A1 (en) Therapeutic Agent for Parkinson's Disease
WO2005056524A3 (en) Therapeutic agents useful for treating pain
CA2545427A1 (en) Selective kinase inhibitors
JP2008511633A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TNSN04213A1 (en) High drug load tablet
JP2001526218A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2002520316A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
DE60001586D1 (de) Diphenyl-piperidin derivate
JP2000159790A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA2302568A1 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
JPH10147529A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO1999033450A3 (en) Pharmaceutical composition containing sibutramine and orlistat
JP2002506864A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA2461963A1 (en) Cyclic amine compounds
RS51923B (en) SO 4 [[4 - [[4- (2-CYANOETHENYL) -2,6-DIMETHYLPHENYL] AMINO] -2-PYRIMIDINYL] AMINO] BENZONITRILA
RU2003130644A (ru) Производные ркарболина и их фармацевтическое применение против дипрессии и страха